Document ID: chunk:federal_register_of_legislation:F2024C00525:reg:62:p2
Version: federal_register_of_legislation:F2024C00525
Segment Type: reg
Provision Reference: reg 62 (pt 2/2)
Character Range: 123604–125623

as in force immediately before the commencement of this section; and
 (c) immediately before the commencement of this section, the period referred to in paragraph 15G(2)(c) of the Act during which a person may apply for review of the decision has not ended;
despite the amendments of section 52 made by Schedule 1 to the Narcotic Drugs Amendment (Medicinal Cannabis) Regulations 2021, Part 4 of Chapter 5 of the Act continues to have effect in relation to the decision as if the amendments had not been made.
 (5) If:
 (a) a decision (the review decision) was made under section 15H of the Act before the commencement of this section; and
 (b) the review decision relates to a decision of the kind referred to in paragraph (4)(b) of this section; and
 (c) immediately before the commencement of this section, both of the following apply:
 (i) an application for review of the review decision by the Administrative Appeals Tribunal had not been made;
 (ii) the time for a person to make such an application has not ended (including any extensions of that time under section 29 of the Administrative Appeals Tribunal Act 1975);
despite the amendments of section 52 made by Schedule 1 to the Narcotic Drugs Amendment (Medicinal Cannabis) Regulations 2021, sections 15L, 15M and 15N of the Act continue, after the commencement of this section, to have effect in relation to the review decision as if the amendments had not been made.
 (6) The amendments of section 56, made by Schedule 1 to the Narcotic Drugs Amendment (Medicinal Cannabis) Regulations 2021, apply in relation to:
 (a) in the case of paragraphs 56(a) and (e)—applications made on or after the commencement of this section; and
 (b) in the case of paragraphs 56(c), (d), (f) and (g)—licences granted on or after the commencement of this section.
 (7) Clause 1 of Schedule 1, as amended by Schedule 1 to the Narcotic Drugs Amendment (Medicinal Cannabis) Regulations 2021, applies in relation to applications made on or after the commencement of this section.